{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:05:10Z","timestamp":1784646310866,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.semdp.2026.151012","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:09:56Z","timestamp":1778753396000},"page":"151012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Old school, new insight: Revisiting histomorphology in the modern era of prostate cancer risk stratification"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1653-4942","authenticated-orcid":false,"given":"Jane K.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semdp.2026.151012_bib0001","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically Localized Prostate Cancer: AUA\/ASTRO Guideline, part I: introduction, risk assessment, staging, and risk-based management","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.semdp.2026.151012_bib0002","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.eururo.2015.08.038","article-title":"Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic resonance imaging and recommendations for use","volume":"69","author":"Barentsz","year":"2016","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.semdp.2026.151012_bib0003","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS Prostate Imaging - Reporting and Data System: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"issue":"10071","key":"10.1016\/j.semdp.2026.151012_bib0004","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet Lond Engl"},{"issue":"5","key":"10.1016\/j.semdp.2026.151012_bib0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.euo.2018.12.007","article-title":"Validation of the decipher test for predicting distant metastatic recurrence in men with high-risk nonmetastatic prostate cancer 10 years after surgery","volume":"2","author":"Van den Broeck","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.semdp.2026.151012_bib0006","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1186\/1471-2164-14-690","article-title":"Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies","volume":"14","author":"Knezevic","year":"2013","journal-title":"BMC Genomics"},{"issue":"6","key":"10.1016\/j.semdp.2026.151012_bib0007","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/bjc.2012.39","article-title":"Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort","volume":"106","author":"Cuzick","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semdp.2026.151012_bib0008","article-title":"Artificial intelligence predictive model for hormone therapy use in prostate cancer","author":"Spratt","year":"2023","journal-title":"Res Sq"},{"issue":"2","key":"10.1016\/j.semdp.2026.151012_bib0009","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2026.151012_bib0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.juro.2016.01.120","article-title":"Prognostic value of percent gleason grade 4 at prostate biopsy in predicting prostatectomy pathology and recurrence","volume":"196","author":"Cole","year":"2016","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.semdp.2026.151012_bib0011","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/PAS.0000000000000691","article-title":"Prognostic significance of percentage and architectural types of contemporary Gleason pattern 4 prostate cancer in radical prostatectomy","volume":"40","author":"Choy","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.semdp.2026.151012_bib0012","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/PAS.0000000000000235","article-title":"Gleason score 3\u2009+\u20094=7 prostate cancer with minimal quantity of Gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen","volume":"38","author":"Huang","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2026.151012_bib0013","first-page":"139","article-title":"Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis","volume":"32","author":"Hollemans","year":"2019","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"issue":"5","key":"10.1016\/j.semdp.2026.151012_bib0014","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/his.14064","article-title":"Clinical outcome comparison of grade group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy","volume":"76","author":"Hollemans","year":"2020","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.semdp.2026.151012_bib0015","first-page":"457","article-title":"Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer","volume":"28","author":"Kweldam","year":"2015","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"issue":"4","key":"10.1016\/j.semdp.2026.151012_bib0016","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00428-015-1809-5","article-title":"Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy","volume":"467","author":"Keefe","year":"2015","journal-title":"Virchows Arch Int J Pathol"},{"issue":"11","key":"10.1016\/j.semdp.2026.151012_bib0017","first-page":"1695","article-title":"Impact of cribriform pattern 4 and intraductal prostatic carcinoma on National Comprehensive Cancer Network (NCCN) and Cancer of Prostate Risk Assessment (CAPRA) patient stratification","volume":"35","author":"Yu","year":"2022","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"issue":"8","key":"10.1016\/j.semdp.2026.151012_bib0018","first-page":"1126","article-title":"Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer","volume":"30","author":"Kweldam","year":"2017","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"key":"10.1016\/j.semdp.2026.151012_bib0019","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.urology.2025.01.061","article-title":"Prognostic value of cribriform and intraductal carcinoma in grade group 2 prostate cancer with and without synchronous nodal metastases at radical prostatectomy: results from a case-control matched, multicenter study","volume":"199","author":"de Barros","year":"2025","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.semdp.2026.151012_bib0020","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/00000658-190912000-00015","article-title":"XV. Cancer of the prostate","volume":"50","author":"Young","year":"1909","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.semdp.2026.151012_bib0021","first-page":"125","article-title":"Classification of prostatic carcinomas","volume":"50","author":"Gleason","year":"1966","journal-title":"Cancer Chemother Rep"},{"issue":"3","key":"10.1016\/j.semdp.2026.151012_bib0022","first-page":"129","article-title":"Survival rates of patients with prostatic cancer, tumor stage, and differentiation\u2013preliminary report","volume":"50","author":"Bailar","year":"1966","journal-title":"Cancer Chemother Rep"},{"issue":"9","key":"10.1016\/j.semdp.2026.151012_bib0023","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","article-title":"Egevad LL, ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of prostatic carcinoma","volume":"29","author":"Epstein","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.semdp.2026.151012_bib0024","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","article-title":"A contemporary prostate cancer grading system: a validated alternative to the Gleason score","volume":"69","author":"Epstein","year":"2016","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.semdp.2026.151012_bib0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","article-title":"The 2019 Genitourinary Pathology Society (GUPS) White Paper on contemporary grading of prostate cancer","volume":"145","author":"Epstein","year":"2021","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"10.1016\/j.semdp.2026.151012_bib0026","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.semdp.2026.151012_bib0027","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/PAS.0000000000001664","article-title":"A comparison of Genitourinary Pathology Society (GUPS) and International Society of Urological Pathology (ISUP) Prostate Cancer Grading guidelines","volume":"45","author":"Epstein","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2026.151012_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAP.0000000000000287","article-title":"Similarities and differences in the 2019 ISUP and GUPS recommendations on prostate cancer grading: a guide for practicing pathologists","volume":"28","author":"Smith","year":"2021","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2026.151012_bib0029","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/his.70046","article-title":"The Genitourinary Pathology Society and International Society of Urological Pathology Joint Expert Consultation Recommendations on intraductal carcinoma of the prostate","volume":"88","author":"Shah","year":"2026","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.semdp.2026.151012_bib0030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/his.13878","article-title":"Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes","volume":"75","author":"Shah","year":"2019","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.semdp.2026.151012_bib0031","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/PAS.0000000000002376","article-title":"Atypical intraductal proliferation in prostate needle core biopsy: validation as a marker of unsampled adverse pathology in a clinicopathologic series of 142 new patients","volume":"49","author":"Bhattarai","year":"2025","journal-title":"Am J Surg Pathol"},{"issue":"0","key":"10.1016\/j.semdp.2026.151012_bib0032","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.eururo.2025.02.029","article-title":"Genitourinary Pathology Society and International Society of Urological Pathology White Paper on defining indolent prostate cancer: call for a multidisciplinary approach","volume":"88","author":"Shah","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.semdp.2026.151012_bib0033","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1097\/PAS.0000000000002425","article-title":"Genitourinary Pathology Society and International Society of Urological Pathology White Paper on defining indolent prostate cancer","volume":"49","author":"Shah","year":"2025","journal-title":"Am J Surg Pathol Publish Online"},{"issue":"2","key":"10.1016\/j.semdp.2026.151012_bib0034","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/his.70023","article-title":"In reply to: \u2018prostate cancer with favorable histology is not synonymous with prostate cancer indolence","volume":"88","author":"McKenney","year":"2026","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.semdp.2026.151012_bib0035","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.5858\/2005-129-1004-ACOIRO","article-title":"A comparison of interobserver reproducibility of Gleason grading of prostatic carcinoma in Japan and the United States","volume":"129","author":"Oyama","year":"2005","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.semdp.2026.151012_bib0036","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1080\/21681805.2016.1206619","article-title":"Interobserver variability in Gleason histological grading of prostate cancer","volume":"50","author":"Ozkan","year":"2016","journal-title":"Scand J Urol"},{"issue":"2","key":"10.1016\/j.semdp.2026.151012_bib0037","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.juro.2011.03.115","article-title":"The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional study","volume":"186","author":"McKenney","year":"2011","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.semdp.2026.151012_bib0038","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.mpdhp.2022.03.001","article-title":"Cribriform prostate cancer: an aggressive pattern where definition and size matter","volume":"28","author":"Chan","year":"2022","journal-title":"Diagn Histopathol"},{"issue":"8","key":"10.1016\/j.semdp.2026.151012_bib0039","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/PAS.0000000000001728","article-title":"ISUP consensus definition of cribriform pattern prostate cancer","volume":"45","author":"van der Kwast","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2026.151012_bib0040","first-page":"139","article-title":"Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis","volume":"32","author":"Hollemans","year":"2019","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"issue":"1","key":"10.1016\/j.semdp.2026.151012_bib0041","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1309\/AJCPZ7WBU9YXSJPE","article-title":"Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome","volume":"136","author":"Iczkowski","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.semdp.2026.151012_bib0042","first-page":"1092","article-title":"Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25\u2009mm diameter as an optimal definition for \u201clarge\u201d cribriform prostatic adenocarcinoma","volume":"35","author":"Chan","year":"2022","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"issue":"8","key":"10.1016\/j.semdp.2026.151012_bib0043","first-page":"3990","article-title":"Diagnosis of \u201ccribriform\u201d prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations","volume":"11","author":"Shah","year":"2021","journal-title":"Am J Cancer Res"},{"issue":"12","key":"10.1016\/j.semdp.2026.151012_bib0044","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0000000000000714","article-title":"Interobserver reproducibility of percent gleason pattern 4 in prostatic adenocarcinoma on prostate biopsies","volume":"40","author":"Sadimin","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.semdp.2026.151012_bib0045","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/his.15469","article-title":"Current practices in prostate pathology reporting: results from a survey of genitourinary and general pathologists","volume":"87","author":"Nourbakshs","year":"2025","journal-title":"Histopathol Publish Online"},{"issue":"11","key":"10.1016\/j.semdp.2026.151012_bib0046","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/PAS.0000000000000736","article-title":"Histologic grading of prostatic adenocarcinoma can Be further optimized: analysis of the relative prognostic strength of individual architectural patterns in 1275 patients from the Canary retrospective cohort","volume":"40","author":"McKenney","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.semdp.2026.151012_bib0047","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.euf.2025.04.027","article-title":"Gleason grade group 3 represents a spectrum of disease: results from a large institutional cohort","volume":"12","author":"Shee","year":"2026","journal-title":"Eur Urol Focus"},{"issue":"4","key":"10.1016\/j.semdp.2026.151012_bib0048","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/his.15231","article-title":"Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage","volume":"85","author":"Nguyen","year":"2024","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.semdp.2026.151012_bib0049","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2019.07.051","article-title":"Improved prostate cancer biopsy grading by incorporation of invasive cribriform and intraductal carcinoma in the 2014 grade groups","volume":"77","author":"van Leenders","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.semdp.2026.151012_bib0050","article-title":"Classification of prostatic adenocarcinoma as favorable\/unfavorable histology has high interobserver agreement in prostate needle core biopsies","author":"Ding","year":"2026","journal-title":"Accept Revis"},{"key":"10.1016\/j.semdp.2026.151012_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2024.152427","article-title":"Correlation of large cribriform carcinoma and \u201cunfavorable histology\u201d with other Gleason pattern 4 subtypes: a proof-of-principle study evaluating 485 radical prostatectomy specimens with proposal for the concept of \u201cborderline histology","volume":"75","author":"Nguyen","year":"2025","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.semdp.2026.151012_bib0052","author":"Accessed"},{"key":"10.1016\/j.semdp.2026.151012_bib0053","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1200\/JCO.2025.43.5_suppl.408","article-title":"Risk stratification using the Decipher 22-gene genomic classifier (GC) and digital pathology artificial intelligence (DPAI) in nearly 10,000 localized prostate cancer patients","volume":"43","author":"Spratt","year":"2025","journal-title":"J Clin Oncol"},{"issue":"0","key":"10.1016\/j.semdp.2026.151012_bib0054","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2025.05.008","article-title":"Prostate cancer active surveillance without biopsy? Not quite yet, but watch this space","volume":"88","author":"Cooperberg","year":"2025","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.semdp.2026.151012_bib55","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/his.70036","article-title":"Correlation of unfavourable and favourable histology at radical prostatectomy with Decipher scores and freedom from biochemical recurrence","volume":"88","author":"Greenland","year":"2026","journal-title":"Histopathology"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257026000328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257026000328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:53:31Z","timestamp":1784645611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257026000328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0740257026000328"],"URL":"https:\/\/doi.org\/10.1016\/j.semdp.2026.151012","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Old school, new insight: Revisiting histomorphology in the modern era of prostate cancer risk stratification","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semdp.2026.151012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151012"}}